Oligonucleotide CDMO market projected to reach $11.14 billion by 2031

Aug 31, 2026 14:15 (21d ago)

Verifying

MarketsandMarkets forecasts global oligonucleotide CDMO market growth through 2031.
USD 3.88 billion in 2026 is projected to reach USD 11.14 billion by 2031.
North America held 43.2% of the market in 2025, according to MarketsandMarkets.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.